[Visceral leishmaniasis associated with human immunodeficiency virus infection (reply)]

Enferm Infecc Microbiol Clin. 2002 Mar;20(3):133. doi: 10.1016/s0213-005x(02)72766-3.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / immunology
  • AIDS-Related Opportunistic Infections / prevention & control*
  • Amphotericin B / administration & dosage*
  • Amphotericin B / therapeutic use
  • Antimony / administration & dosage*
  • Antimony / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Drug Administration Schedule
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • Humans
  • Immunocompromised Host
  • Leishmaniasis, Visceral / drug therapy
  • Leishmaniasis, Visceral / immunology
  • Leishmaniasis, Visceral / prevention & control*
  • Prospective Studies
  • Recurrence
  • Spain / epidemiology
  • Viral Load

Substances

  • Amphotericin B
  • Antimony